Comparison of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Yuzuncu Yıl University

Status: Completed

Conditions: Soft Tissue Bleeding; Postoperative Pain; Wound Heal

Treatments: Device: 2780 nm Er,Cr:YSGG Laser; Device: 940 nm Gallium Aluminum Arsenide Diode Laser

Study type: Interventional

Funder types: Other

Identifiers

NCT03819244

24112017-01

Details and patient eligibility

About

The study evaluates postoperative pain, intraoperative bleeding and wound healing after second stage implant surgery. Submerged implants were exposed with diode laser in Group 1 (n=20) and by using Er,Cr:YSGG laser in Group 2 (n=20).

Enrollment: 40 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• subject has osseointegrated implants embedded under oral mucosa.
• subject undergoes second-stage implant surgery.

Exclusion criteria

• inadequate keratinized gingiva in the implant site.
• localization of the implant site is not possible due to excessive thickness of the oral mucosa

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Diode laser

Experimental group

Description:

Soft tissue incision with 940 nm Gallium Aluminum Arsenide diode laser, at implant recovery settings (2.5 W output power, average power: 1.25 W, pulse length : 1.00 ms, pulse interval: 1.00 ms) in second-stage implant surgery.

Treatment:

Device: 940 nm Gallium Aluminum Arsenide Diode Laser

Erbium laser

Experimental group

Description:

Soft tissue incision with 2780 nm Er,Cr:YSGG laser, at implant recovery settings (2.00 W power, 100 Hz, H mode, 10% water and 10% air) in second-stage implant surgery.

Treatment:

Device: 2780 nm Er,Cr:YSGG Laser